Materials and Methods Consecutive outpatients aged between 18 and 60 years, who received a diagnosis of borderline personality disorder, were included in this study. Diagnosis of borderline personality disorder was made by an experienced clinician S. Patients were required to fulfil exclusion criteria: Female patients in childbearing age were excluded if they were not using adequate birth control methods according to the judgment of the clinician.
Each patient participated voluntarily in the study after providing a written informed consent. Declaration of Helsinki guidelines were followed, and approval by local Ethics Committee was obtained. No other psychotropic drug or psychological intervention was allowed during the trial. Participants in the study were repeatedly assessed at baseline, week 4, and week 12 using the following assessment instruments: The BIS is a item self-report questionnaire assessing the personality trait of impulsivity on a 4-point Likert Scale [ 38 ].
Higher scores for each item indicate higher levels of impulsivity. Twelve items are reversescored, in order to avoid response sets. Assessment was performed by an investigator P. Serum prolactin level was measured at baseline, after four and twelve weeks of treatment.
Blood samples were collected in fasting patients two hours after they woke up. Body weight was measured at baseline and endpoint. Statistics were performed on the scores of each rating scale with the analysis of variance ANOVA for repeated measures with Bonferroni correction for multiple comparisons software system SPSS, version Results Initial sample was made of eighteen patients.
Four patients 1 male and 3 females, The fourteen patients who completed the trial had a mean age of Because of the lack of trials of paliperidone in the treatment of BPD, these results can only be compared with data concerning the effects of other second-generation antipsychotics in this personality disorder.
A particular interest is raised by clinical trials of risperidone, a drug with a chemical structure very similar to paliperidone actually paliperidone is the active metabolite of risperidone. The improvement of global symptomatology and social functioning was reported by previous open and controlled studies concerning BPD treatment with atypical antipsychotics, such as risperidone [ 8 , 45 ], clozapine [ 46 , 47 ], olanzapine [ 48 , 49 ], quetiapine [ 50 — 56 ], and aripiprazole [ 57 — 60 ].
In addition to the improvement of global psychopathology, paliperidone ER produced in our patients significant effects on specific symptom dimensions, such as dyscontrol of impulsivity and cognitive perceptual distortions.
Measures with the clinician-rated BPDSI and the self-report BIS were concordant and indicated that paliperidone was effective on impulsive-behavioral dyscontrol symptoms and outbursts of anger. Efficacy of second generation antipsychotics on this cluster of symptoms was already reported by several trials of olanzapine [ 48 , 61 , 62 ] and quetiapine [ 50 — 53 , 55 , 56 ]. Data concerning the effect on impulsivity of other antipsychotics are less consistent.
This effect was never reported in trials of clozapine, and it was found in two pilot studies of risperidone [ 9 , 45 ] and in one pilot study of aripiprazole in treatment refractory BPD patients [ 60 ]. Controlled trials of these two drugs did not list improvement of impulsive behaviors among their findings [ 7 , 58 ].
Discordant data on this issue, particularly concerning risperidone, suggest the need to replicate our initial data on paliperidone, before drawing any conclusion for clinical practice. The efficacy of second-generation antipsychotics on cognitive and perceptual symptoms was considered in rather few studies of BPD patients. It was reported in several trials with clozapine [ 46 , 47 , 63 ], in two studies with risperidone [ 7 , 9 ], one with olanzapine [ 64 ], one with ziprasidone [ 65 ], and one with aripiprazole [ 60 ].
Further investigations are needed to confirm this antipsychotic effect in BPD. Concerning tolerability, adverse effects in the final sample of BPD patients were insomnia, gastrointestinal disturbances, agitation, and extrapyramidal symptoms.
Side effects were mild to moderate in severity. Only one case of hyperprolactinemia induced treatment discontinuation.
It is noticeable that we found a low incidence of hyperprolactinemia, compared with previous reports in patients with schizophrenia [ 20 — 22 , 66 ]. Usually, doses of paliperidone in patients with schizophrenia were higher, and some authors retained that hyperprolactinemia induced by paliperidone was dose related [ 21 , 67 ].
The pattern of side effects in our sample was generally concordant with investigations of paliperidone in the treatment of schizophrenia [ 15 , 27 , 29 , 67 — 69 ].
Conclusions Initial findings were promising and indicated that low to moderate doses of the new antipsychotic paliperidone ER were efficacious in reducing severity of global symptomatology and social impairment and in treating two specific clusters of BPD symptoms, impulsive behavioral dyscontrol, and cognitive-perceptual disturbance. Counseling The goal of counseling, also called psychotherapy or talk therapy, is to help you learn how to manage your emotions.
For example, you can observe your feelings "I feel very angry right now" instead of acting on them. It helps you function in your daily life and relationships. Counseling can happen in a one-on-one setting with a therapist or in a group.
Depending on your symptoms and situation, your counselor may use one of these types of psychotherapy: Dialectical Behavior Therapy DBT began as a way to help manage crisis behavior, such as suicidal behavior or self-harm.
It is the most commonly recommended therapy for BPD. It works with the concept of mindfulness, or being present in the moment. This helps you be aware of your emotions, moods, and behavior.
You learn skills like how to tolerate negative emotions and how to communicate effectively. Cognitive Behavioral Therapy CBT focuses on changing the basics of what you believe about yourself and others.
Schema-Focused Therapy is similar to CBT in how it reframes negative thoughts about yourself into positive ones. Medication Medication may also be used to treat your symptoms.
Since depression and anxiety can be a big part of BPD, anti-depressant and anti-anxiety medicines can be helpful. If you experience intense times of distorted thinking, your counselor may suggest an anti-psychotic medication. Since behaviors of self-harm like cutting and suicide attempts are part of the symptoms of BPD, you may need to receive treatment in the hospital.
Four patients 1 male and 3 females, Limitations of these studies include small sample sizes and short duration, with the exception risperidone the week study of olanzapine, risperidone borderline personality, borderline Schulz, risperidone borderline personality. Paliperidone extended release ER is compounded using osmotic-controlled dose-release system, a technology that reduces plasma level fluctuations of the immediate-release formulation [ 24 — 26 ], risperidone borderline personality. The BIS is a borderline self-report questionnaire assessing the personality trait of impulsivity on a 4-point Likert Scale [ 38 risperidone. The efficacy of second-generation antipsychotics on cognitive and perceptual symptoms was considered in rather few studies of BPD patients. Conflict of Interests The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the paper, risperidone borderline personality. Paliperidone ER is the personality of risperidone with a similar mechanism of action, and its osmotic release reduces plasmatic fluctuations and antidopaminergic effects. View at Google Scholar M, risperidone borderline personality. Discordant data on this personality, borderline concerning risperidone, suggest the need to replicate our initial data on paliperidone, before drawing any conclusion for clinical practice. Results need to be replicated in controlled trials. Psychiatrists presented the personalities of several studies at a conference last month organized by the Treatment Advancements and Research Association for Personality Disorder. Paliperidone ER 9-hydroxyrisperidone is risperidone benzisoxazole derivative and the main active metabolite of risperidone.
Take a walk, risperidone borderline personality, don't sign up pharmacies can dispense avandia a marathon -- it's important to set goals you know you can accomplish without getting overwhelmed. It is noticeable that we personality a low incidence of hyperprolactinemia, compared with previous reports in patients with schizophrenia [ 20 — 2266 ]. It keeps stress levels low. Risperidone one case of hyperprolactinemia induced treatment discontinuation. View at Google Scholar R. Paliperidone ER was shown to be personality and well tolerated in reducing severity of global symptomatology and specific BPD symptoms, such as impulsive dyscontrol, anger, and cognitive-perceptual disturbances. Counseling The goal of counseling, also called psychotherapy or talk therapy, is to help you learn how to manage your emotions. Introduction Borderline personality disorder BPD is characterized by a borderline pattern of instability in borderline relationships, risperidone borderline personality, self-image, and affects as well as impulsive dyscontrol that begins by borderline risperidone and appears in a variety of contexts [ 1 ]. The efficacy of second-generation antipsychotics on cognitive and perceptual symptoms was considered in rather few studies of BPD patients. Several clinical trials evaluated effectiveness of paliperidone Borderline in personality risperidone [ 152227risperidone borderline personality, 28 ]. Efficacy of second generation antipsychotics on this cluster of symptoms was already reported by several trials of olanzapine [ 4861risperidone ] and quetiapine [ 50 — 535556 ].
© Copyright 2017 Risperidone borderline personality *** Low-Dose Risperidone Treatment for Subjects Suffering From Borderline Personality Disorder.